KCAS Bio

KCAS Bio is a bioanalytical contract research organization (CRO) that supports drug development worldwide across complex therapeutic modalities. They provide GLP/GCP‑compliant bioanalytical services—including PK/PD analysis, method development and validation, immunogenicity and biomarker assays, and regulated sample testing—for small molecules, biologics, and advanced therapies. Clients rely on KCAS Bio for experienced scientific teams, robust quality and regulatory systems, and global project management to accelerate programs from discovery through clinical development.